For medicines and ph... 申请号：JP2018544459 专利类型：发明申请 公开（公告）日：
状态：寻求转化 转让价格：面议
A pharmaceutical product can be distributed to respective patients in a plurality of jurisdictions. First and second jurisdictions can have different labeling requirements than each other. A plurality...
For inhibition of cy... 申请号：JP2018551176 专利类型：发明申请 公开（公告）日：
状态：寻求转化 转让价格：面议
The present invention relates to compounds, and pharmaceutically acceptable compositions thereof, useful as inhibitors of cyclophilins, and for the treatment of cyclophilin-related disorders.
For inhibition of cy... 申请号：JP2018551179 专利类型：发明申请 公开（公告）日：
状态：寻求转化 转让价格：面议
The present invention relates to compounds, and pharmaceutically acceptable compositions thereof, useful as inhibitors of cyclophilins, and for the treatment of cyclophilin-related disorders.
For inhibition of cy... 申请号：JP2018551217 专利类型：发明申请 公开（公告）日：
状态：寻求转化 转让价格：面议
The present invention relates to compounds, and pharmaceutically acceptable compositions thereof, useful as inhibitors of cyclophilins, and for the treatment of cyclophilin-related disorders.
For improving the sk... 申请号：JP2014089906 专利类型：发明授权 公开（公告）日：2014-04-24
状态：寻求转化 转让价格：面议
[PROBLEM] The problem to be solved by the invention is to provide a novel pharmaceutical use of a JAK inhibitor. [SOLUTION MEANS] A therapeutic or preventive agent for a skin disease selected from th...
For improved safety ... 申请号：JP2018535858 专利类型：发明申请 公开（公告）日：2017-01-10
状态：寻求转化 转让价格：面议
There is disclosed a chimeric infliximab-like monoclonal antibody having at least 80% NANA glycosylation terminal sialic acid and a glycosylation pattern of Gal-α(2, 3/6)-Gal that binds to tumor necro...
For important docume... 申请号：JP2007007139U 专利类型：实用新型 公开（公告）日：
状态：寻求转化 转让价格：面议
PROBLEM TO BE SOLVED : binder system even more document file can be added, moreover, even in the normal document even with relatively thick booklet together all the document file a new real estate ...
For immunotherapy of... 申请号：JP2018545230 专利类型：发明申请 公开（公告）日：
状态：寻求转化 转让价格：面议
The present invention relates to engineered immune cells expressing antigen receptors, such as a T cell receptor (TCR) or a chimeric antigen receptor (CAR), as well as antibody targeting PD-L1. Also...
For gene therapy usi... 申请号：JP2018534551 专利类型：发明申请 公开（公告）日：2017-01-03
状态：寻求转化 转让价格：面议
Methods are provided for the cell-based delivery of collagen VII for the treatment of Epidermolysis Bullosa and corneal erosion. The disclosure also provides a composition and a pharmaceutical composi...
